Indian Pharma Industry Likely to Grow at 10-13 % in FY21: ICRA
“The Indian pharmaceutical industry’s growth remained stable at 12.2 per cent during H1FY2020 led by rebound in domestic growth in Q2 FY2020 to 14.2 per cent supported by seasonal factors and stable growth in chronic therapies,” said Mr Gaurav Jain, ICRA Vice President & Co-Head.